sulforaphane has been researched along with sapropterin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JM; Hwang, O; Kim, EM; Kim, HW; Lee, SY; Lee, YJ; Moon, Y | 1 |
| Ding, H; El-Daly, M; Hirota, SA; Hollenberg, MD; Pulakazhi Venu, VK; Saifeddine, M; Triggle, CR | 1 |
2 other study(ies) available for sulforaphane and sapropterin
| Article | Year |
|---|---|
Protective effect of sulforaphane against dopaminergic cell death.
Topics: Biopterins; Cell Death; Cell Membrane; Cells, Cultured; Chromosomes; DNA Fragmentation; Dopamine; Humans; Immunohistochemistry; Isothiocyanates; L-Lactate Dehydrogenase; Oxidopamine; Quinones; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Sulfoxides; Thiocyanates | 2007 |
Minimizing Hyperglycemia-Induced Vascular Endothelial Dysfunction by Inhibiting Endothelial Sodium-Glucose Cotransporter 2 and Attenuating Oxidative Stress: Implications for Treating Individuals With Type 2 Diabetes.
Topics: Biomarkers; Biopterins; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Humans; Hyperglycemia; Incidence; Isothiocyanates; Oxidative Stress; Prognosis; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfoxides | 2019 |